<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font22 { font-size : 22; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font30">the </span>
   <span class="font22">al., </span>
   <span class="font17">for </span>
   <span class="font16">with </span>
   <span class="font15">patients </span>
   <span class="font14">COVID- </span>
   <span class="font14">that </span>
   <span class="font13">viral </span>
   <span class="font13">treatment </span>
   <span class="font13">SARS-CoV- </span>
   <span class="font13">clinical </span>
   <span class="font12">are </span>
   <span class="font12">against </span>
   <span class="font12">from </span>
   <span class="font12">was </span>
   <span class="font12">coronavirus </span>
   <span class="font12">also </span>
   <span class="font12">NCT, </span>
   <span class="font12">respiratory </span>
   <span class="font11">have </span>
   <span class="font11">vitro </span>
   <span class="font11">The </span>
   <span class="font11">can </span>
   <span class="font11">were </span>
   <span class="font11">severe </span>
   <span class="font11">cells </span>
   <span class="font11">study </span>
   <span class="font11">used </span>
   <span class="font11">has </span>
   <span class="font11">its </span>
   <span class="font11">{background </span>
   <span class="font11">antiviral </span>
   <span class="font11">which </span>
   <span class="font11">chloroquine </span>
   <span class="font11">hydroxychloroquine </span>
   <span class="font11">cell </span>
   <span class="font11">plasma </span>
   <span class="font11">RNA </span>
   <span class="font11">activity </span>
   <span class="font11">virus </span>
   <span class="font11">infection </span>
   <span class="font11">SARS-CoV </span>
   <span class="font11">drug </span>
   <span class="font11">ChiCTR, </span>
   <span class="font11">Med. </span>
   <span class="font11">acute </span>
   <span class="font11">al. </span>
   <span class="font11">efficacy </span>
   <span class="font11">involving </span>
   <span class="font11">margin </span>
   <span class="font11">novel </span>
   <span class="font11">been </span>
   <span class="font11">human </span>
   <span class="font11">studies </span>
   <span class="font11">{border-style </span>
   <span class="font11">COVID-. </span>
   <span class="font11">effective </span>
   <span class="font11">potential </span>
   <span class="font11">reported </span>
   <span class="font10">SARS </span>
   <span class="font10">px;} </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">after </span>
   <span class="font10">convalescent </span>
   <span class="font10">into </span>
   <span class="font10">receptor </span>
   <span class="font10">replication </span>
   <span class="font10">than </span>
   <span class="font10">Vero </span>
   <span class="font10">disease </span>
   <span class="font10">immunomodulatory </span>
   <span class="font10">other </span>
   <span class="font10">Dis. </span>
   <span class="font10">Infect. </span>
   <span class="font10">Wang </span>
   <span class="font10">days </span>
   <span class="font10">infected </span>
   <span class="font10">protein </span>
   <span class="font10">showed </span>
   <span class="font10">shown </span>
   <span class="font10">trials </span>
   <span class="font10">Phase </span>
   <span class="font10">found </span>
   <span class="font10">lung </span>
   <span class="font10">more </span>
   <span class="font10">not </span>
   <span class="font10">protease </span>
   <span class="font10">results </span>
   <span class="font10">vaccines </span>
   <span class="font10">... </span>
   <span class="font10">b). </span>
   <span class="font10">effects </span>
   <span class="font10">favipiravir </span>
   <span class="font10">including </span>
   <span class="font10">syndrome </span>
   <span class="font10">treat </span>
   <span class="font10">treated </span>
   <span class="font10">type </span>
   <span class="font10">various </span>
   <span class="font10">ACE </span>
   <span class="font10">cells, </span>
   <span class="font10">cytokines </span>
   <span class="font10">day </span>
   <span class="font10">inhibitor </span>
   <span class="font10">like </span>
   <span class="font10">mortality </span>
   <span class="font10">oxygen </span>
   <span class="font10">pneumonia </span>
   <span class="font10">safety </span>
   <span class="font10">therapy </span>
   <span class="font10">However, </span>
   <span class="font10">IFN-Î± </span>
   <span class="font10">Res. </span>
   <span class="font10">agents </span>
   <span class="font10">all </span>
   <span class="font10">arbidol </span>
   <span class="font10">being </span>
   <span class="font10">effect </span>
   <span class="font10">group </span>
   <span class="font10">immune </span>
   <span class="font10">inhibit </span>
   <span class="font10">inhibitors </span>
   <span class="font10">may </span>
   <span class="font10">new </span>
   <span class="font10">vaccine </span>
   <span class="font10">(Chen </span>
   <span class="font10">China </span>
   <span class="font10">Chinese </span>
   <span class="font10">Chloroquine </span>
   <span class="font10">States </span>
   <span class="font10">body </span>
   <span class="font10">compared </span>
   <span class="font10">demonstrated </span>
   <span class="font10">drugs </span>
   <span class="font10">host </span>
   <span class="font10">influenza </span>
   <span class="font10">significant </span>
   <span class="font10">Table </span>
   <span class="font10">Virol. </span>
   <span class="font10">candidate </span>
   <span class="font10">care </span>
   <span class="font10">case </span>
   <span class="font10">combination </span>
   <span class="font10">due </span>
   <span class="font10">high </span>
   <span class="font10">higher </span>
   <span class="font10">hospitalized </span>
   <span class="font10">known </span>
   <span class="font10">mice </span>
   <span class="font10">observed </span>
   <span class="font10">patients, </span>
   <span class="font10">polymerase </span>
   <span class="font10">possible </span>
   <span class="font10">receiving </span>
   <span class="font10">remdesivir </span>
   <span class="font10">response </span>
   <span class="font10">standard </span>
   <span class="font10">stem </span>
   <span class="font10">study, </span>
   <span class="font10">trial </span>
   <span class="font10">Î¼M </span>
   <span class="font10">(Antiviral) </span>
   <span class="font10">(Commision, </span>
   <span class="font10">Agents </span>
   <span class="font10">Disease </span>
   <span class="font10">Health </span>
   <span class="font10">Image </span>
   <span class="font10">National </span>
   <span class="font10">administered </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">azithromycin </span>
   <span class="font10">binding </span>
   <span class="font10">critical </span>
   <span class="font10">cytokine </span>
   <span class="font10">during </span>
   <span class="font10">having </span>
   <span class="font10">help </span>
   <span class="font10">inhibits </span>
   <span class="font10">interferon </span>
   <span class="font10">kinase </span>
   <span class="font10">over </span>
   <span class="font10">per </span>
   <span class="font10">preclinical </span>
   <span class="font10">px; </span>
   <span class="font10">received </span>
   <span class="font10">receptors </span>
   <span class="font10">recommended </span>
   <span class="font10">spike </span>
   <span class="font10">suggested </span>
   <span class="font10">their </span>
   <span class="font10">two </span>
   <span class="font10">viruses </span>
   <span class="font10">{font-family </span>
   <span class="font10">â€" </span>
   <span class="font10">(Guan </span>
   <span class="font10">(Wang </span>
   <span class="font10">Arbidol </span>
   <span class="font10">Chen </span>
   <span class="font10">ChiCTR. </span>
   <span class="font10">Clinical </span>
   <span class="font10">East </span>
   <span class="font10">Favipiravir </span>
   <span class="font10">Hydroxychloroquine </span>
   <span class="font10">IL- </span>
   <span class="font10">Middle </span>
   <span class="font10">Traditional </span>
   <span class="font10">a). </span>
   <span class="font10">antibody </span>
   <span class="font10">beneficial </span>
   <span class="font10">between </span>
   <span class="font10">control </span>
   <span class="font10">critically </span>
   <span class="font10">current </span>
   <span class="font10">font-size </span>
   <span class="font10">ill </span>
   <span class="font10">infection. </span>
   <span class="font10">lines </span>
   <span class="font10">mRNA </span>
   <span class="font10">made </span>
   <span class="font10">model </span>
   <span class="font10">origin </span>
   <span class="font10">proteins </span>
   <span class="font10">range </span>
   <span class="font10">rate </span>
   <span class="font10">recombinant </span>
   <span class="font10">recovered </span>
   <span class="font10">reduced </span>
   <span class="font10">research </span>
   <span class="font10">rheumatoid </span>
   <span class="font10">role </span>
   <span class="font10">such </span>
   <span class="font10">support </span>
   <span class="font10">therapies </span>
   <span class="font10">there </span>
   <span class="font10">these </span>
   <span class="font10">tocilizumab </span>
   <span class="font10">treatment. </span>
   <span class="font10">whereas </span>
   <span class="font10">without </span>
   <span class="font10">&amp;amp; </span>
   <span class="font10">(CHNOS) </span>
   <span class="font10">(Furuta </span>
   <span class="font10">(Gautret </span>
   <span class="font10">(Yao </span>
   <span class="font10">Administration </span>
   <span class="font10">Azithromycin </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">HIV- </span>
   <span class="font10">June </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">MSCs </span>
   <span class="font10">May </span>
   <span class="font10">NCT. </span>
   <span class="font10">Sci. </span>
   <span class="font10">Therefore, </span>
   <span class="font10">Tocilizumab </span>
   <span class="font10">United </span>
   <span class="font10">WHO </span>
   <span class="font10">Wuhan, </span>
   <span class="font10">another </span>
   <span class="font10">associated </span>
   <span class="font10">cells. </span>
   <span class="font10">clinically </span>
   <span class="font10">considered </span>
   <span class="font10">corticosteroids </span>
   <span class="font10">days. </span>
   <span class="font10">decrease </span>
   <span class="font10">dexamethasone </span>
   <span class="font10">double; </span>
   <span class="font10">enzyme </span>
   <span class="font10">inflammation </span>
   <span class="font10">inhibited </span>
   <span class="font10">levels </span>
   <span class="font10">mechanical </span>
   <span class="font10">pathogenesis </span>
   <span class="font10">potent </span>
   <span class="font10">preventing </span>
   <span class="font10">rapid </span>
   <span class="font10">regarding </span>
   <span class="font10">ribavirin </span>
   <span class="font10">several </span>
   <span class="font10">some </span>
   <span class="font10">ten </span>
   <span class="font10">use </span>
   <span class="font10">widely </span>
   <span class="font10">(Huang </span>
   <span class="font10">ARDS </span>
   <span class="font10">Acad. </span>
   <span class="font10">Also, </span>
   <span class="font10">Am. </span>
   <span class="font10">Antimicrob. </span>
   <span class="font10">Besides </span>
   <span class="font10">Commission </span>
   <span class="font10">Ebola </span>
   <span class="font10">Elsevier </span>
   <span class="font10">Institute </span>
   <span class="font10">NCT,ChiCTR. </span>
   <span class="font10">Natl. </span>
   <span class="font10">Patients </span>
   <span class="font10">Remdesivir </span>
   <span class="font10">State </span>
   <span class="font10">Treatment </span>
   <span class="font10">Unit. </span>
   <span class="font10">ability </span>
   <span class="font10">about </span>
   <span class="font10">action </span>
   <span class="font10">adverse </span>
   <span class="font10">animal </span>
   <span class="font10">baricitinib </span>
   <span class="font10">benefit </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">both </span>
   <span class="font10">but </span>
   <span class="font10">could </span>
   <span class="font10">currently </span>
   <span class="font10">data </span>
   <span class="font10">different </span>
   <span class="font10">entry </span>
   <span class="font10">first </span>
   <span class="font10">free </span>
   <span class="font10">functions </span>
   <span class="font10">guidelines </span>
   <span class="font10">however, </span>
   <span class="font10">improvement </span>
   <span class="font10">infections </span>
   <span class="font10">inflammatory </span>
   <span class="font10">inhibiting </span>
   <span class="font10">inhibition </span>
   <span class="font10">large </span>
   <span class="font10">lead </span>
   <span class="font10">load </span>
   <span class="font10">might </span>
   <span class="font10">models </span>
   <span class="font10">only </span>
   <span class="font10">pandemic </span>
   <span class="font10">phosphate </span>
   <span class="font10">production </span>
   <span class="font10">proven </span>
   <span class="font10">release </span>
   <span class="font10">remarkable </span>
   <span class="font10">required </span>
   <span class="font10">significantly </span>
   <span class="font10">solid; </span>
   <span class="font10">studies, </span>
   <span class="font10">symptoms </span>
   <span class="font10">target </span>
   <span class="font10">this </span>
   <span class="font10">tract </span>
   <span class="font10">twice </span>
   <span class="font10">using </span>
   <span class="font10">value </span>
   <span class="font10">virus, </span>
   <span class="font10">vivo </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(.%), </span>
   <span class="font10">(ECÂ </span>
   <span class="font10">(Gao </span>
   <span class="font10">(Leng </span>
   <span class="font10">(McCreary </span>
   <span class="font10">(Organization, </span>
   <span class="font10">(Stockman </span>
   <span class="font10">(Xu </span>
   <span class="font10">-nCoV </span>
   <span class="font10">African </span>
   <span class="font10">Antiviral </span>
   <span class="font10">Baricitinib </span>
   <span class="font10">Biological </span>
   <span class="font10">COVID-: </span>
   <span class="font10">Chemother. </span>
   <span class="font10">Clin. </span>
   <span class="font10">Convalescent </span>
   <span class="font10">EUA, </span>
   <span class="font10">I/IINCT. </span>
   <span class="font10">IFN-ÃŸ </span>
   <span class="font10">Ivermectin </span>
   <span class="font10">Knockout </span>
   <span class="font10">MSC </span>
   <span class="font10">Mair-Jenkins </span>
   <span class="font10">Medical </span>
   <span class="font10">Medicine </span>
   <span class="font10">Microbiol. </span>
   <span class="font10">NCT,ChiCTR, </span>
   <span class="font10">Novel </span>
   <span class="font10">One </span>
   <span class="font10">Original </span>
   <span class="font10">Pogue, </span>
   <span class="font10">References </span>
   <span class="font10">SARS-COV- </span>
   <span class="font10">Shenzhen </span>
   <span class="font10">Stem </span>
   <span class="font10">Such </span>
   <span class="font10">TMPRSS </span>
   <span class="font10">University </span>
   <span class="font10">Vaccines </span>
   <span class="font10">Wilde </span>
   <span class="font10">Writing </span>
   <span class="font10">Xiyanping </span>
   <span class="font10">activities </span>
   <span class="font10">administration </span>
   <span class="font10">adults </span>
   <span class="font10">angiotensin </span>
   <span class="font10">anti-viral </span>
   <span class="font10">antivirals </span>
   <span class="font10">approved </span>
   <span class="font10">arthritis </span>
   <span class="font10">aspects </span>
   <span class="font10">available </span>
   <span class="font10">beyond </span>
   <span class="font10">bold </span>
   <span class="font10">broad-spectrum </span>
   <span class="font10">cases </span>
   <span class="font10">centre </span>
   <span class="font10">chemical </span>
   <span class="font10">clearance </span>
   <span class="font10">clearance, </span>
   <span class="font10">compounds </span>
   <span class="font10">concentration </span>
   <span class="font10">concentrations </span>
   <span class="font10">conditions </span>
   <span class="font10">confirmed </span>
   <span class="font10">courier; </span>
   <span class="font10">death </span>
   <span class="font10">distress </span>
   <span class="font10">documented </span>
   <span class="font10">dose </span>
   <span class="font10">efficient </span>
   <span class="font10">elevated </span>
   <span class="font10">em; </span>
   <span class="font10">even </span>
   <span class="font10">evidence </span>
   <span class="font10">express </span>
   <span class="font10">findings </span>
   <span class="font10">followed </span>
   <span class="font10">fusion </span>
   <span class="font10">given </span>
   <span class="font10">global </span>
   <span class="font10">had </span>
   <span class="font10">improved </span>
   <span class="font10">increase </span>
   <span class="font10">increased </span>
   <span class="font10">injury </span>
   <span class="font10">interaction </span>
   <span class="font10">intracellular </span>
   <span class="font10">invasive </span>
   <span class="font10">issued </span>
   <span class="font10">longer </span>
   <span class="font10">lopinavir </span>
   <span class="font10">lopinavir-ritonavir </span>
   <span class="font10">lopinavir/ritonavir </span>
   <span class="font10">mainly </span>
   <span class="font10">many </span>
   <span class="font10">mesenchymal </span>
   <span class="font10">mg/ml </span>
   <span class="font10">million </span>
   <span class="font10">monoclonal </span>
   <span class="font10">mouse </span>
   <span class="font10">nanoparticle </span>
   <span class="font10">need </span>
   <span class="font10">nucleoside </span>
   <span class="font10">one </span>
   <span class="font10">outcomes </span>
   <span class="font10">particles </span>
   <span class="font10">patient </span>
   <span class="font10">patients. </span>
   <span class="font10">profile </span>
   <span class="font10">promising </span>
   <span class="font10">properties </span>
   <span class="font10">pt;} </span>
   <span class="font10">recent </span>
   <span class="font10">reducing </span>
   <span class="font10">resource </span>
   <span class="font10">review </span>
   <span class="font10">severity </span>
   <span class="font10">showing </span>
   <span class="font10">stimulation </span>
   <span class="font10">storm </span>
   <span class="font10">suppression </span>
   <span class="font10">susceptibility </span>
   <span class="font10">synergistically </span>
   <span class="font10">systematic </span>
   <span class="font10">therapeutic </span>
   <span class="font10">therefore, </span>
   <span class="font10">they </span>
   <span class="font10">threat </span>
   <span class="font10">three </span>
   <span class="font10">tocilizumab, </span>
   <span class="font10">total </span>
   <span class="font10">treatment, </span>
   <span class="font10">under </span>
   <span class="font10">ventilation </span>
   <span class="font10">via </span>
   <span class="font10">where </span>
   <span class="font10">will </span>
   <span class="font10">within </span>
   <span class="font10">â€"Â </span>
  </p>
 </body>
</html>
